The amyloid-β isoform pattern in cerebrospinal fluid in familial PSEN1 M139T- and L286P-associated Alzheimer's disease

JA HardyGA HigginsAlzheimer's disease: the amyloid cascade hypothesisScience2561841851992

CA LemereJK BlusztajnH YamaguchiT WisniewskiTC SaidoDJ SelkoeSequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formationNeurobiol Dis31632199610.1006/nbdi.1996.00039173910

A Rovelet-LecruxD HannequinG RauxAPP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathyNat Genet382426200610.1038/ng171816369530

D BeherJD WrigleyAP OwensMS ShearmanGeneration of C-terminally truncated amyloid-beta peptides is dependent on gamma-secretase activityJ Neurochem82563575200210.1046/j.1471-4159.2002.00985.x12153480

E PorteliusE PriceG BrinkmalmA novel pathway for amyloid precursor protein processingNeurobiol Aging3210901098201110.1016/j.neurobiolaging.2009.06.00219604603

E PorteliusH ZetterbergU AndreassonAn Alzheimer's disease-specific beta-amyloid fragment signature in cerebrospinal fluidNeurosci Lett4092152192006

E PorteliusU AndreassonJM RingmanDistinct cerebrospinal fluid amyloid beta peptide signatures in sporadic and PSEN1 A431E-associated familial Alzheimer's diseaseMol Neurodegener52201010.1186/1750-1326-5-220145736

E PorteliusB Van BroeckU AndreassonAcute effect on the Abeta isoform pattern in CSF in response to γ-secretase modulator and inhibitor treatment in dogsJ Alzheimers Dis2110051012201020634579

E PorteliusB ZhangMK GustavssonEffects of gamma-secretase inhibition on the amyloid beta isoform pattern in a mouse model of Alzheimer's diseaseNeurodegener Dis6258262200910.1159/00026463919955704

E PorteliusRA DeanMK GustavssonA novel Abeta isoform pattern in CSF reflects gamma-secretase inhibition in Alzheimer diseaseAlzheimers Res Ther27201010.1186/alzrt3020350302

JJ CookKR WildsmithDB GilbertoAcute gamma-secretase inhibition of nonhuman primate CNS shifts amyloid precursor protein (APP) metabolism from amyloid-beta production to alternative APP fragments without amyloid-beta reboundJ Neurosci3067436750201010.1523/JNEUROSCI.1381-10.201020463236

A GoateMC Chartier-HarlinM MullanSegregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's diseaseNature349704706199110.1038/349704a0

E Levy-LahadW WascoP PoorkajCandidate gene for the chromosome 1 familial Alzheimer's disease locusScience269973977199510.1126/science.7638622

R SherringtonEI RogaevY LiangCloning of a gene bearing missense mutations in early-onset familial Alzheimer's diseaseNature375754760199510.1038/375754a0

M BentahirO NyabiJ VerhammePresenilin clinical mutations can affect gamma-secretase activity by different mechanismsJ Neurochem96732742200610.1111/j.1471-4159.2005.03578.x16405513

M CitronD WestawayW XiaMutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic miceNat Med367721997

S Kumar-SinghJ TheunsB Van BroeckMean age-of-onset of familial alzheimer disease caused by presenilin mutations correlates with both increased Abeta42 and decreased Abeta40Hum Mutat27686695200610.1002/humu.20336

JM RingmanSG YounkinD PraticoBiochemical markers in persons with preclinical familial Alzheimer diseaseNeurology718592200810.1212/01.wnl.0000303973.71803.8118509095

J ForteaA LladoJ ClarimonPICOGEN: Five years experience with a genetic counselling program for dementiaNeurologia26143149201121163230

R Sanchez-ValleA LladoM EzquerraMJ ReyL RamiJL MolinuevoA novel mutation in the PSEN1 gene (L286P) associated with familial early-onset dementia of Alzheimer type and lobar haematomasEur J Neurol1414091412200710.1111/j.1468-1331.2007.01988.x18028191

J ForteaA LladoB BoschCerebrospinal fluid biomarkers in Alzheimer's disease families with PSEN1 mutationsNeurodegener Dis8202207201110.1159/000322229

E PorteliusAJ TranU AndreassonCharacterization of amyloid beta peptides in cerebrospinal fluid by an automated immunoprecipitation procedure followed by mass spectrometryJ Proteome Res644334439200710.1021/pr070362717927230

K BlennowH HampelM WeinerH ZetterbergCerebrospinal fluid and plasma biomarkers in Alzheimer diseaseNat Rev Neurol6131144201010.1038/nrneurol.2010.420157306

U AndreassonE PorteliusME AnderssonK BlennowH ZetterbergAspects of beta-amyloid as a biomarker for Alzheimer's diseaseBiomark Med15978200710.2217/17520363.1.1.59

E PorteliusN BogdanovicMK GustavssonMass spectrometric characterization of brain amyloid beta isoform signatures in familial and sporadic Alzheimer's diseaseActa Neuropathol120185193201010.1007/s00401-010-0690-120419305